...
首页> 外文期刊>Biochimica et biophysica acta. Reviews on cancer >Targeting transcription factor NF-kappaB to overcome chemoresistance and radioresistance in cancer therapy.
【24h】

Targeting transcription factor NF-kappaB to overcome chemoresistance and radioresistance in cancer therapy.

机译:在癌症治疗中靶向转录因子NF-κB以克服化学抗性和放射抗性。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Activation of transcription factor NF-kappaB is frequently encountered in tumor cells and contributes to aggressive tumor growth and resistance to chemotherapy and ionizing radiation during cancer treatment. Accumulating evidence over the last few years indicate that most chemotherapeutic agents and radiation therapy activate NF-kappaB in vitro and in vivo. Moreover, induction of chemoresistance and radioresistance is mediated through several genes regulated by NF-kappaB and inhibition of this transcription factor increases sensitivity of cancer cells to the apoptotic action of chemotherapeutic agents and to radiation exposure. This review explores the role of NF-kappaB and its regulated genes in resistance of tumor cells to chemotherapeutic agents and radiation and evaluates the importance of targeting NF-kappaB as a potential therapeutic approach to overcome chemoresistance and radioresistance for cancer treatment.
机译:转录因子NF-κB的激活在肿瘤细胞中经常遇到,并且有助于积极的肿瘤生长以及在癌症治疗期间对化学疗法和电离辐射的抵抗力。过去几年中越来越多的证据表明,大多数化学治疗剂和放射疗法在体外和体内均可激活NF-κB。而且,化学抗性和放射抗性的诱导是通过NF-κB调节的几个基因介导的,对该转录因子的抑制增加了癌细胞对化学治疗剂的凋亡作用和对辐射暴露的敏感性。这篇综述探讨了NF-κB及其调控基因在肿瘤细胞对化学治疗剂和放射线的抗性中的作用,并评估了靶向NF-κB作为克服化学耐药性和抗癌性的潜在治疗方法的重要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号